Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillation
- PMID: 36340482
- PMCID: PMC9626881
- DOI: 10.1016/j.hroo.2022.07.010
Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillation
Abstract
Background: Atrial fibrillation (AF) is the most common heart rhythm disorder among adults and leads to substantial morbidity and mortality.
Objectives: The purpose of the study was to provide current estimates on the incremental healthcare utilization and cost burden associated with incident AF diagnosis in the United States.
Methods: Adults with an incident diagnosis of AF (2017-2020) were identified using the Optum Clinformatics database. Propensity matching was employed to match patients with incident AF to a comparator group of non-AF patients on several demographic and clinical characteristics. Outcomes including 12-month all-cause and cardiovascular (CV)-related healthcare utilization, as well as the medical cost associated with health services use, were assessed. Logistic and general linear models were used to examine study outcomes. Sub-analyses were performed to determine the incremental AF burden by specific sex and racial/ethnic categories.
Results: A total of 79,621 patients were identified in each cohort (AF and non-AF). As compared to the non-AF cohort, patients with AF had significantly higher all-cause inpatient visits (relative risk [RR] 1.77; 95% confidence interval [CI] 1.76-1.78), CV-related inpatient visits (RR 2.51; 95% CI 2:49-2:53), and CV-related emergency room visits (RR: 2.41; 95% CI 2:35-2:47). The mean total healthcare cost for patients with AF was $27,896 more (per patient per year) than the non-AF cohort ($63,031 vs $35,135, P < .001).
Conclusion: Medical services utilization and cost were significantly higher among AF patients than non-AF patients. Early treatment is likely to be critical to addressing the considerable disease burden imposed by AF.
Keywords: Atrial fibrillation; Health burden; Healthcare utilization; Medical costs; United States.
© 2022 Heart Rhythm Society. Published by Elsevier Inc.
Figures



References
-
- Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002;415:219–226. - PubMed
-
- Lippi G., Sanchis-Gomar F., Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16:217–221. - PubMed
-
- Williams B.A., Honushefsky A.M., Berger P.B. Temporal trends in the incidence, prevalence, and survival of patients with atrial fibrillation from 2004 to 2016. Am J Cardiol. 2017;120:1961–1965. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials